Home

Paradigm Biopharmaceuticals (ASX:PAR) - Webinar Presentation

PUBLISHED

2023-10-13

Content

Paul Rennie - Founder and Managing Director - Paradigm Biopharmaceuticals Limited (ASX:PAR) is a global biopharmaceutical company. Its current focus is a drug for the treatment of osteoarthritis.

Author